CHGA Projected Dividend Yield
Change Agents Corp ( NASDAQ : CHGA )Avalon GloboCare is a clinical-stage CellTech bio-developer focused on advancing and empowering transformative immune effector cell therapy and laboratory services. Co. also provides advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as engage in healthcare and CellTech industry markets. Co. is engaging in the fields of cellular immunotherapy (including chimeric antigen receptor-T/NK), exosome technology (Avalon Clinical-grade Tissue-specific Exosome), and regenerative therapeutics. 22 YEAR PERFORMANCE RESULTS |
|
CHGA Dividend History Detail CHGA Dividend News CHGA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |


